KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Gilead Sciences (GILD) Return on Equity (2016 - 2025)

Historic Return on Equity for Gilead Sciences (GILD) over the last 17 years, with Q3 2025 value amounting to 0.39%.

  • Gilead Sciences' Return on Equity rose 3900.0% to 0.39% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.39%, marking a year-over-year increase of 3900.0%. This contributed to the annual value of 0.02% for FY2024, which is 2300.0% down from last year.
  • Per Gilead Sciences' latest filing, its Return on Equity stood at 0.39% for Q3 2025, which was up 3900.0% from 0.33% recorded in Q2 2025.
  • Gilead Sciences' Return on Equity's 5-year high stood at 0.39% during Q3 2025, with a 5-year trough of 0.01% in Q3 2024.
  • For the 5-year period, Gilead Sciences' Return on Equity averaged around 0.21%, with its median value being 0.25% (2023).
  • In the last 5 years, Gilead Sciences' Return on Equity crashed by -2600bps in 2024 and then soared by 3900bps in 2025.
  • Gilead Sciences' Return on Equity (Quarter) stood at 0.29% in 2021, then fell by -26bps to 0.22% in 2022, then rose by 15bps to 0.25% in 2023, then crashed by -90bps to 0.03% in 2024, then surged by 1450bps to 0.39% in 2025.
  • Its Return on Equity was 0.39% in Q3 2025, compared to 0.33% in Q2 2025 and 0.31% in Q1 2025.